What's Behind Japan Firms' Higher Approval Rates In Challenging Oncology, CNS Areas?

Alliances Play A Key Role

 
• By Lisa Takagi
In the US market, top 11 Japanese pharmaceutical firms have shown high LOA compared to benchmarks.
Top Japanese pharma firms show relatively high US LOAs • Source: Shutterstock

More from R&D

More from Scrip